COVID-19: WHO issues emergency-use listing for by Serum Institute of India’s Covovax
Adar Poonawalla, the CEO of Serum Institute of India (SII), hailed WHO’s decision as “yet another milestone” in the fight against COVID-19. The World Health Organisation on Friday issued emergency use listing for anti-Covid vaccine Covovax produced by Serum Institute of India under licence from Novavax, expanding the basket of jabs validated by the global … Read more